Cardiovascular Institute

Stanford women's cardiovascular health program was initiated in 2006, spearheaded by Stanford Cardiovascular Institute director Robert C. Robbins, M.D.

Our Mission

The Mission of “Women’s Heart Health at Stanford” is to:


Co-Director: Hannah Valantine, MD, Professor of Cardiovascular Medicine
Dr. Valantine, a cardiologist, is Senior Associate Dean for Diversity and Leadership at Stanford University Medical Center. She is President of the Western States Affiliate Board of the American Heart Association and a frequent speaker at national and international meetings on heart disease and women’s issues.

Co-Director: Marcia Stefanick, PhD, Professor of Medicine-Prevention Research, and, by courtesy, of Obstetrics and Gynecology
Dr. Stefanick is active in a national Think Tank of cardiologists and researchers focused on Women and Heart Disease, is promoting the Investigation of Sex and Gender Differences in Cardiovascular Research across the wide spectrum of research areas represented by Stanford CVI members, and is an acknowledged expert on women’s health issues (especially cardiovascular) and disease prevention, is frequently interviewed and sought-after as a speaker nationally and internationally.

Clinical Director: Jennifer Tremmel, MD, SM (Epidemiology). Dr. Tremmel is an Instructor and Interventional Cardiologist in the Division of Cardiovascular Medicine.  She also trained in Preventive Cardiology and was a Postdoctoral Research Scholar at the Stanford Prevention Research Center.  Dr. Tremmel is the Clinical Director of Women’s Heart Health at Stanford, as well as the Director of the Stanford Secondary Prevention Program.  Dr. Tremmel’s research interests include sex differences in coronary artery disease, the determinants of vascular access complications, and the effects of weight on coronary physiology and cardiac outcomes.  She has also evaluated the use of drug-eluting stents in transplant arteriopathy and keeps Stanford’s Tako-Tsubo Patient Registry.  She is currently investigating sex differences in the occurrence of coronary endothelial dysfunction, diffuse plaque deposition, and microvascular disease in women and men presenting with chest pain, but having “normal” coronary arteries by angiography.

Stanford Medicine Resources:

Footer Links: